Why the study?
Are high NT-pro-BNP levels associated with more vulnerable coronary plaque components in patients with acute coronary syndrome?
Observational (n=156)
Are high NT-pro-BNP levels associated with more vulnerable coronary plaque components in patients with acute coronary syndrome?
Absolute Event Rate: 19.8% vs 15.2%
p-value: p=0.027
In patients with ACS, elevated NT-pro-BNP levels are associated with more vulnerable coronary plaque characteristics, including larger necrotic cores and more frequent, proximally located thin-cap fibroatheromas.
Supports NT-proBNP as marker of plaque vulnerability in ACS; leaves open whether it improves risk prediction or management.
BACKGROUND: The N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is a sensitive indicator of hemodynamic stress and its increased level is associated with higher mortality in acute coronary syndrome (ACS) patients. Virtual histology-intravascular ultrasound (VH-IVUS) can provide quantitative information on plaque components. METHODS: We measured preprocedural serum NT-pro-BNP levels in 156 ACS patients with preserved left ventricular systolic function and normal serum creatinine. VH-IVUS classified the color-coded tissue into four major components: fibrotic, fibro-fatty, dense calcium, and necrotic core (NC). Thin-cap fibroatheroma (TCFA) was defined as focal, NC-rich (>or=10% of the cross-sectional area) plaques being in contact with the lumen in a plaque burden of at least 40%. We divided the patients into two groups according to the NT-pro-BNP levels [group I: >or=200 pg/ml (n = 58) vs. group II: <200 pg/ml (n = 98)]. RESULTS: The percent areas of NC at the minimum lumen site (19.8+/-13.1% vs. 15.2+/-11.1%, P = 0.027) and at the largest NC site (24.7+/-10.3% vs. 19.2+/-11.4%, P = 0.015) were significantly greater in group I than in group II. Percent NC volume was significantly greater in group I than in group II (15.8+/-8.1% vs. 10.1+/-9.1%, P = 0.008). The total number of TCFAs was 38 in group I and 56 in group II. The presence of at least one TCFA (58 vs. 38%, P = 0.009) and multiple TCFAs (25 vs. 10%, P = 0.005) within culprit lesions were observed more frequently in group I than in group II. The TCFAs were located more in proximal in group I than in group II [the length from coronary ostium to TCFA: 10.8+/-7.6 mm in group I vs. 25.7+/-16.3 mm in group II (P<0.001)]: 85% of TCFAs was located within 20 mm from coronary ostium in group I; conversely only 36% of TCFAs was located within 20 mm from coronary ostium in group II (P<0.001). CONCLUSION: VH-IVUS analysis shows that ACS patients with high NT-pro-BNP levels had more vulnerable plaque component (more NC-containing lesions and higher frequency of culprit lesion TCFAs) and had more proximally located TCFAs.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2009) conducted an observational in acute coronary syndrome (n=156). High NT-pro-BNP levels (≥200 pg/ml) vs. Low NT-pro-BNP levels (<200 pg/ml) was evaluated on Percent areas of necrotic core at the minimum lumen site (p=0.027).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: